The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Glucose Metabolism and Regulation: Beyond Insulin and Glucagon
Abstract
Insulin and glucagon are potent regulators of glucose metabolism. For decades, we have viewed diabetes from a bi-hormonal perspective of glucose regulation. This perspective is incomplete and inadequate in explaining some of the difficulties that patients and practitioners face when attempting to tightly control blood glucose concentrations. Intensively managing diabetes with insulin is fraught with frustration and risk. Despite our best efforts,glucose fluctuations are unpredictable, and hypoglycemia and weight gain are common. These challenges may be a result of deficiencies or abnormalities in other glucoregulatory hormones. New understanding of the roles of other pancreatic and incretin hormones has led to a multi-hormonal view of glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Glucagon and regulation of glucose metabolism
Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905
Vilsbøll, T., Krarup, T., Deacon, C. F., Madsbad, S., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.3.609 · Cited by 884
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869
Hypoglycemia in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.2.271 · Cited by 746
International Textbook of Diabetes Mellitus
(2004) · Wiley eBooks · doi:10.1002/0470862092 · Cited by 725
Elliott, R. M., Morgan, L. M., Tredger, J. A., Deacon, S., Wright, J., & Marks, V. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1380159 · Cited by 695
Nauck, M. A., Heimesaat, M. M., Behle, K., Holst, J. J., Nauck, M. S., Ritzel, R., Hüfner, M., & Schmiegel, W. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8355 · Cited by 605
Herrmann, C., Göke, R., Richter, G., Fehmann, H.-C., Arnold, R., & Göke, B. (2009) · Digestion · doi:10.1159/000201231 · Cited by 597
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
Drucker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2929 · Cited by 579
Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
Drucker, D. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0306 · Cited by 483
Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects
Horowitz, M., Edelbroek, M. A. L., Wishart, J. M., & Straathof, J. W. (1993) · Diabetologia · doi:10.1007/bf00400362 · Cited by 469
Purnell, J. Q., Hokanson, J. E., Marcovina, S. M., Steffes, M. W., Cleary, P. A., & Brunzell, J. D. (1998) · JAMA · doi:10.1001/jama.280.2.140 · Cited by 469
American Diabetes Association: clinical practice recommendations 1996.
(1996) · PubMed · Cited by 430
Amylin, Calcitonin Gene-Related Peptide, Calcitonin, and Adrenomedullin: A Peptide Superfamily
Wimalawansa, S. J. (1997) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v11.i2-3.40 · Cited by 424
Minireview: The Glucagon-Like Peptides
Drucker, D. J. (2001) · Endocrinology · doi:10.1210/en.142.2.521 · Cited by 421
Insulin analogues and their potential in the management of diabetes mellitus
Bolli, G. B., Di Marchi, R. D., Park, G. D., Pramming, S., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051286 · Cited by 349
Weight Gain Associated With Intensive Therapy in the Diabetes Control and Complications Trial
The DCCT Research Group (1988) · Diabetes Care · doi:10.2337/diacare.11.7.567 · Cited by 345
Baron, A. D., Schaeffer, L., Shragg, P., & Kolterman, O. G. (1987) · Diabetes · doi:10.2337/diab.36.3.274 · Cited by 308
GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans
Näslund, E., Bogefors, J., Skogar, S., Grybäck, P., Jacobsson, H., Holst, J. J., & Hellström, P. M. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r910 · Cited by 284
Glucose Counterregulation in Man
Cryer, P. E. (1981) · Diabetes · doi:10.2337/diab.30.3.261 · Cited by 270
Glucagon physiology and pathophysiology
Sherwood, L. M., Parris, E. E., & Unger, R. H. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108192850806 · Cited by 267
GIF biology and fat metabolism
Yip, R. G. C., & Wolfe, M. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00314-8 · Cited by 266
Glucagonlike peptide 1: a newly discovered gastrointestinal hormone
Holst, J. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90831-1 · Cited by 252
Burcelin, R., Da Costa, A., Drucker, D., & Thorens, B. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1720 · Cited by 250
The importance of the β-cell in the pathogenesis of type 2 diabetes mellitus
Kahn, S. E. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00336-3 · Cited by 242
Gerich, J. E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80207-1 · Cited by 224
High affinity amylin binding sites in rat brain.
Beaumont, K., Kenney, M. A., Young, A. A., & Rink, T. J. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13212-4 · Cited by 208
Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment.
Ogawa, A., Harris, V, McCorkle, S. K., Unger, R. H., & Luskey, K. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114528 · Cited by 205
Amylin: A Novel Action in the Brain to Reduce Body Weight
Rushing, P. A. (2000) · Endocrinology · doi:10.1210/en.141.2.850 · Cited by 201
Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM
Dinneen, S., Alzaid, A., Turk, D., & Rizza, R. (1995) · Diabetologia · doi:10.1007/bf00400639 · Cited by 190
Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man.
Gerich, J., Davis, J., Lorenzi, M., Rizza, R., Bohannon, N., Karam, J., Lewis, S., Kaplan, R., Schultz, T., & Cryer, P. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.4.e380 · Cited by 183
The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus
Fujimoto, W. Y. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00337-5 · Cited by 183
Dose-response for glucagonostatic effect of amylin in rats
Gedulin, B. R., Rink, T. J., & Young, A. A. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90170-0 · Cited by 180
Inhibition of Central Amylin Signaling Increases Food Intake and Body Adiposity in Rats
Rushing, P. A. (2001) · Endocrinology · doi:10.1210/en.142.11.5035 · Cited by 174
Weyer, C., Maggs, D., Young, A., & Kolterman, O. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397357 · Cited by 174
Bruttomesso, D., Pianta, A., Mari, A., Valerio, A., Marescotti, M. C., Avogaro, A., Tiengo, A., & Del Prato, S. (1999) · Diabetes · doi:10.2337/diabetes.48.1.99 · Cited by 166
Moore, C. X., & Cooper, G. J. S. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91325-7 · Cited by 148
Samsom, M., Szarka, L. A., Camilleri, M., Vella, A. V., Zinsmeister, A. R., & Rizza, R. A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g946 · Cited by 148
Amylin concentrations and glucose control
Koda, J., Fineman, M. S., RINK, T. J., Dailey, G., Muchmore, D. B., & Linarelli, L. G. (1992) · The Lancet · doi:10.1016/0140-6736(92)90785-2 · Cited by 145
Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for Type 2-diabetes
Nauck, M. A., Holst, J. J., Willms, B., & Schmiegel, W. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211750 · Cited by 145
Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function
Perfetti, R., & Merkel, P. A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430717 · Cited by 145
Heinemann, L., Heise, T., Wahl, L. C., TRAUTMANN, M. E., Ampudia‐Blasco, F. J., Starke, A. A. R., & Berger, M. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199607)13:7<625::aid-dia134>3.0.co;2-2 · Cited by 122
Synergy between amylin and cholecystokinin for inhibition of food intake in mice
Bhavsar, S., Watkins, J., & Young, A. W. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00110-3 · Cited by 121
Characterization of the Glucagon Response to Hypoglycemia in Man
Gerich, J. E., Schneider, V. B., Dippe, S. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-1-77 · Cited by 120
Rachman, J., Gribble, F. M., Barrow, B. A., Lévy, J., Buchanan, K. D., & Turner, R. C. (1996) · Diabetes · doi:10.2337/diab.45.11.1524 · Cited by 119
Pehling, G. B., Tessari, P., Gerich, J. E., Mw, H., Service, F. J., & Rizza, R. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111519 · Cited by 117
Glucagon and its Family Revisited
Lefèbvre, P. J. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.715 · Cited by 112
Amylinʼs physiology and its role in diabetes
Young, A. A. (1997) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199708000-00006 · Cited by 88
Lugari, R., Dei, A., Ugolotti, D., Finardi, L., Barilli, A., Ognibene, C. M., Luciani, A., Zandomeneghi, R., & GNUDI, A. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-23199 · Cited by 85
Clinical Implications of Amylin and Amylin Deficiency
Kruger, D. F., Gatcomb, P., & Owen, S. K. (1999) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572179902500310 · Cited by 79
Jacobs, M., Keulen, E. T. P., Kanc, K., Casteleijn, S., Scheffer, P. G., Devillé, W. L. J. M., & Heine, R. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.8.1279 · Cited by 77
van Rossum, D., Ménard, D. P., Fournier, A., St-Pierre, S. A., & Quirion, R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22436-3 · Cited by 75
Cell Contacts in Human Islets of Langerhans
Orci, L., MALAISSE-LAGAE, F., AMHERDT, M., Ravazzola, M., Weisswange, A., DOBBS, R. E., Perrelet, A., & Unger, R. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-5-841 · Cited by 74
Buse, J. B., Weyer, C., & Maggs, D. G. (2002) · Clinical Diabetes · doi:10.2337/diaclin.20.3.137 · Cited by 71
The Medical Management of Hyperglycemia Over a 10-Year Period in People With Diabetes
Klein, R., Klein, R., Moss, S. E., & Cruickshanks, K. J. (1996) · Diabetes Care · doi:10.2337/diacare.19.7.744 · Cited by 61
Glucagon-like peptide-1 (7–36 amide): a potent glucagonostatic and insulinotropic hormone
Matsuyama, T., Komatsu, R., Namba, M., Watanabe, N., Itoh, H., & Tarui, S. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80063-9 · Cited by 58
Type 1 diabetes mellitus and the use of flexible insulin regimens.
Hirsch, I. B. (1999) · PubMed · Cited by 50
Heise, T., Heinemann, L., Heller, S. R., Weyer, C., Wang, Y., Strobel, S. A., Kolterman, O., & Maggs, D. G. (2004) · Metabolism · doi:10.1016/j.metabol.2004.04.010 · Cited by 29
Section Review Oncologic, Endocrine & Metabolic: The amylin, CGRP and calcitonin family of peptides
Beeley, N. R. A., & Prickett, K. S. (1996) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.6.6.555 · Cited by 9
Cited by
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591
Diabetes-induced hyperglycemia impairs male reproductive function: A systematic review
Maresch, C. C., Stute, D. C., Alves, M. G., Oliveira, P. F., de Kretser, D. M., & Linn, T. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx033 · Cited by 294
Pedersen, A. F., Meyer, D. N., Petriv, A.-M. V., Soto, A. L., Shields, J. N., Akemann, C., Baker, B. B., Tsou, W.-L., Zhang, Y., & Baker, T. R. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115090 · Cited by 162
The macronutrients, appetite, and energy intake
Carreiro, A. L., Dhillon, J., Gordon, S., Higgins, K. A., Jacobs, A. G., McArthur, B. M., Redan, B. W., Rivera, R. L., Schmidt, L. R., & Mattes, R. D. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-121415-112624 · Cited by 159
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective
De Block, C., Bailey, C., Wysham, C., Hemmingway, A., Allen, S. E., & Peleshok, J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14831 · Cited by 121
Metadata
- Authors
- Aronoff, S. L., Berkowitz, K., Shreiner, B., & Want, L.
- Venue
- Diabetes Spectrum
- Publisher
- American Diabetes Association
- Published
- 2004-07-01
- Volume
- 17
- Issue
- 3
- Pages
- 183-190
- ISSN
- 1040-9165 (ISSN-L)
- 1944-7353
- OpenAlex
- W2140791028
- Cited by
- 569
- References
- 69
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.